UnitedHealth Group (NYSE:UNH – Get Free Report) was upgraded by investment analysts at StockNews.com from a “hold” rating to a “buy” rating in a research report issued on Wednesday.
A number of other research analysts have also issued reports on UNH. Robert W. Baird initiated coverage on shares of UnitedHealth Group in a research note on Thursday, May 30th. They set an “outperform” rating and a $597.00 target price for the company. Piper Sandler boosted their target price on shares of UnitedHealth Group from $566.00 to $571.00 and gave the company an “overweight” rating in a research note on Wednesday, April 17th. Cantor Fitzgerald reaffirmed an “overweight” rating and issued a $591.00 price target on shares of UnitedHealth Group in a research note on Tuesday. Wells Fargo & Company reduced their price target on shares of UnitedHealth Group from $600.00 to $525.00 and set an “overweight” rating for the company in a research note on Monday, April 8th. Finally, TD Cowen reduced their price target on shares of UnitedHealth Group from $607.00 to $546.00 and set a “buy” rating for the company in a research note on Wednesday, April 10th. Two investment analysts have rated the stock with a hold rating, eighteen have issued a buy rating and one has given a strong buy rating to the company. According to data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and a consensus price target of $581.44.
View Our Latest Analysis on UNH
UnitedHealth Group Price Performance
UnitedHealth Group (NYSE:UNH – Get Free Report) last announced its quarterly earnings data on Tuesday, April 16th. The healthcare conglomerate reported $6.91 earnings per share for the quarter, beating analysts’ consensus estimates of $6.63 by $0.28. The business had revenue of $99.80 billion during the quarter, compared to the consensus estimate of $99.23 billion. UnitedHealth Group had a net margin of 4.05% and a return on equity of 26.50%. The company’s revenue for the quarter was up 8.6% compared to the same quarter last year. During the same quarter in the prior year, the firm earned $6.26 EPS. On average, sell-side analysts anticipate that UnitedHealth Group will post 27.55 EPS for the current year.
Institutional Inflows and Outflows
Several large investors have recently added to or reduced their stakes in UNH. Richelieu Gestion SA bought a new stake in UnitedHealth Group in the fourth quarter worth approximately $26,000. CGC Financial Services LLC boosted its holdings in shares of UnitedHealth Group by 1,000.0% during the 4th quarter. CGC Financial Services LLC now owns 55 shares of the healthcare conglomerate’s stock worth $29,000 after buying an additional 50 shares during the period. True Wealth Design LLC bought a new stake in shares of UnitedHealth Group during the 4th quarter worth $31,000. Delos Wealth Advisors LLC boosted its holdings in shares of UnitedHealth Group by 757.1% during the 1st quarter. Delos Wealth Advisors LLC now owns 60 shares of the healthcare conglomerate’s stock worth $30,000 after buying an additional 53 shares during the period. Finally, LFA Lugano Financial Advisors SA boosted its holdings in shares of UnitedHealth Group by 148.1% during the 4th quarter. LFA Lugano Financial Advisors SA now owns 67 shares of the healthcare conglomerate’s stock worth $35,000 after buying an additional 40 shares during the period. Institutional investors and hedge funds own 87.86% of the company’s stock.
About UnitedHealth Group
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.
Recommended Stories
- Five stocks we like better than UnitedHealth Group
- 3 Stocks to Protect Your Portfolio from the Coronavirus Contagion
- Sales Breakout Sends This Semiconductor Stock to Record High
- Procter & Gamble (NYSE:PG) Pulls Back After Shaky Guidance
- Surprise Buying Opportunity on This Dividend Aristocrat
- Where Do I Find 52-Week Highs and Lows?
- New Theme Park Powerhouse: Merger Creates Industry-Leading Stock
Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.